What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His main research concerns Internal medicine, Cancer, Oncology, Chemotherapy and Cancer research.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery.
His biological study spans a wide range of topics, including Monoclonal, Microsatellite instability and Pathology.
His Oncology research includes themes of Clinical endpoint, Clinical trial and Carcinoma.
The Chemotherapy study combines topics in areas such as Prospective cohort study, Capecitabine and Oxaliplatin.
His Cancer research research integrates issues from Mutation, Anaplastic lymphoma kinase, ALK inhibitor, Receptor tyrosine kinase and ROS1.
His most cited work include:
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes (770 citations)
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial (474 citations)
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone (443 citations)
What are the main themes of his work throughout his whole career to date?
Jeeyun Lee focuses on Internal medicine, Oncology, Cancer, Cancer research and Chemotherapy.
His Internal medicine research incorporates themes from Gastroenterology, Surgery and Pathology.
In his study, Cisplatin is inextricably linked to Capecitabine, which falls within the broad field of Oncology.
His research integrates issues of Immunohistochemistry, Radiation therapy, Microsatellite instability and Hazard ratio in his study of Cancer.
His work deals with themes such as Cell growth, Mutation, KRAS, Gene and Antibody, which intersect with Cancer research.
His Chemotherapy study frequently links to adjacent areas such as Clinical endpoint.
He most often published in these fields:
- Internal medicine (59.90%)
- Oncology (42.35%)
- Cancer (37.36%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (59.90%)
- Cancer (37.36%)
- Cancer research (24.64%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cancer, Cancer research, Oncology and Chemotherapy.
In his research, Capecitabine is intimately related to Gastroenterology, which falls under the overarching field of Internal medicine.
Jeeyun Lee studied Cancer and Hazard ratio that intersect with Adjuvant therapy.
His work carried out in the field of Cancer research brings together such families of science as Cell growth, RNA, Immune system, KRAS and Antibody.
His Oncology research is multidisciplinary, relying on both Biomarker, Primary tumor, Advanced gastric cancer and Immunotherapy.
His study on Chemotherapy is mostly dedicated to connecting different topics, such as Randomized controlled trial.
Between 2018 and 2021, his most popular works were:
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. (64 citations)
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer (61 citations)
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial. (51 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Internal medicine, Cancer, Oncology, Cancer research and Chemotherapy.
His Internal medicine study typically links adjacent topics like Gastroenterology.
His Cancer research incorporates elements of Stage, Receptor, Microsatellite instability and Cohort.
His Oncology research is multidisciplinary, relying on both Cohort study, Young adult, Survival rate, Biomarker and Immunotherapy.
His Cancer research research incorporates elements of KRAS, Antibody, Kinase and Phase i study.
The various areas that he examines in his Chemotherapy study include Stage ii, Visual acuity and Vandetanib.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
